Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA) Insider Trading
Directors, officers and holders of more than 10% of NTLA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 106 transactions on file: 1 with code P, 17 with code S and 32 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 26, 2026 | Marantz Jing L. | EVP, Chief Medical Officer | A Award | 199,822 | Not measured | Not measured |
| Oct 26, 2026 | Marantz Jing L. | EVP, Chief Medical Officer | A Award | 275,061 | Not measured | Not measured |
| Oct 2, 2026 | Dube Michael P | VP, Chief Accounting Officer | S Sale | 1,864 | $12.43 | $23,170 |
| Aug 21, 2026 | LEONARD JOHN M | President and CEO | S Sale | 2,785 | $13.00 | $36,205 |
| Aug 20, 2026 | LEONARD JOHN M | President and CEO | S Sale | 19,890 | $12.60 | $250,614 |
| Jul 22, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 8,111 | $11.25 | $91,249 |
| Jul 2, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 4,677 | $18.00 | $84,186 |
| Jul 1, 2026 | Dube Michael P | VP, Chief Accounting Officer | S Sale | 2,641 | $16.78 | $44,316 |
| Jun 9, 2026 | Bhanji Muna | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Cohen Fred E | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | Keresty Georgia | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | CHASE WILLIAM J | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | Cohen Fred E | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Bhanji Muna | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | GOODMAN JESSE | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | CHASE WILLIAM J | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Goff Brian | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Goff Brian | Director | A Award | 9,200 | Not measured | Not measured |
| Jun 9, 2026 | GOODMAN JESSE | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Verwiel Frank | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Keresty Georgia | Director | A Award | 13,300 | Not measured | Not measured |
| Jun 9, 2026 | Verwiel Frank | Director | A Award | 9,200 | Not measured | Not measured |
| Mar 2, 2026 | Clark Eliana | EVP, Chief Technical Officer | S Sale | 607 | $13.78 | $8,364 |
| Mar 2, 2026 | BASTA JAMES | EVP, General Counsel | S Sale | 1,211 | $13.78 | $16,688 |
| Mar 1, 2026 | Dube Michael P | VP, Chief Accounting Officer | A Award | 17,250 | Not measured | Not measured |
| Mar 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | A Award | 7,353 | Not measured | Not measured |
| Mar 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | A Award | 14,204 | Not measured | Not measured |
| Mar 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | A Award | 39,200 | Not measured | Not measured |
| Mar 1, 2026 | Lebwohl David | EVP, Chief Medical Officer | A Award | 9,943 | Not measured | Not measured |
| Mar 1, 2026 | BASTA JAMES | EVP, General Counsel | A Award | 65,829 | Not measured | Not measured |
| Mar 1, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | A Award | 56,000 | Not measured | Not measured |
| Mar 1, 2026 | BASTA JAMES | EVP, General Counsel | A Award | 46,080 | Not measured | Not measured |
| Mar 1, 2026 | LEONARD JOHN M | President and CEO | A Award | 225,400 | Not measured | Not measured |
| Mar 1, 2026 | LEONARD JOHN M | President and CEO | A Award | 156,400 | Not measured | Not measured |
| Mar 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | A Award | 61,280 | Not measured | Not measured |
| Mar 1, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | A Award | 87,543 | Not measured | Not measured |
| Mar 1, 2026 | Clark Eliana | EVP, Chief Technical Officer | A Award | 10,505 | Not measured | Not measured |
| Jan 5, 2026 | Dulac Edward J III | EVP, Chief Financial Officer | S Sale | 6,379 | $9.21 | $58,751 |
| Jan 5, 2026 | Dube Michael P | VP, Chief Accounting Officer | S Sale | 2,989 | $9.21 | $27,529 |
| Jan 5, 2026 | Clark Eliana | EVP, Chief Technical Officer | S Sale | 9,515 | $9.21 | $87,633 |
| Jan 5, 2026 | BASTA JAMES | EVP, General Counsel | S Sale | 10,397 | $9.21 | $95,756 |
| Jan 5, 2026 | Cohen Fred E | Director | P Purchase | 150,000 | $9.35 | $1,402,500 |
| Jan 5, 2026 | Lebwohl David | EVP, Chief Medical Officer | S Sale | 11,903 | $9.21 | $109,627 |
| Jan 5, 2026 | LEONARD JOHN M | President and CEO | S Sale | 34,146 | $9.21 | $314,485 |
| Jan 5, 2026 | Schultes Birgit C | EVP, Chief Scientific Officer | S Sale | 8,508 | $9.21 | $78,359 |
| Dec 12, 2025 | LEONARD JOHN M | President and CEO | M Exercise | 8,557 | $6.83 | $58,444 |
| Dec 12, 2025 | LEONARD JOHN M | President and CEO | M Exercise | 8,557 | Not measured | Not measured |
| Dec 11, 2025 | LEONARD JOHN M | President and CEO | M Exercise | 49,959 | $6.83 | $341,220 |
| Dec 11, 2025 | LEONARD JOHN M | President and CEO | S Sale | 5,355 | $9.59 | $51,354 |
| Dec 11, 2025 | LEONARD JOHN M | President and CEO | S Sale | 32,832 | $9.47 | $310,919 |
The full Form 4 history is on the NTLA company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.